Biobanking Transforming Personalized Medicine Ecosystem with Data on Biomarkers

The collected terabytes of biological data and its associated information are revolutionizing healthcare infrastructure across nations. Likewise, stakeholders in the biobanking market are increasing their focus on personalized medicines to meet the growing demand for the specific diagnosis for rare-case diseases. In 2017, North America topped the list of major countries in the world, and contributed ~17% of its GDP towards healthcare spending. Correspondingly, North America is projected to dominate market revenue throughout the forecast period in the biobanking market.

Healthcare companies are seeking result-oriented outcomes in personalized medicine space though the development of new drugs. This is being made possible with the help of high-quality biospecimens from biobanks. Thus, stakeholders in the biobanking market and healthcare companies are closely related, as the early detection and prevention of diseases is heavily dependent upon the data received by companies on specific biomarkers. Growing awareness about the types of cancer, cardiovascular diseases, and neurological disorders are paving the way for emanant development of a personalized medicine ecosystem.

biobanking market infographic

Request a sample to get extensive insights into the Biobanking Market  

Stakeholders Shifting Focus from Sample-driven to Data-driven Strategies

The digital revolution is contributing to the growth of precision medicine research. Likewise, precision medicine research and clinical data are closely related. Although, in many cases, there are instances of weak associations between the two variables. This works as a profitable opportunity for stakeholders in the biobanking market, as the availability of data on well-characterized and high quality samples is of primary importance to healthcare companies.

In order to create strong associations between precision medicine research and clinical data, stakeholders in the biobanking landscape are introducing artificial intelligence (AI) and big data analytics. This has helped in faster research, which has positively influenced the delivery of new drugs in the healthcare space. Thus, there is the growing need for increasing informatics capabilities in the biobanking market.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Modern biobanking requires the gathering and administration of large amounts of sample data, so that medical researchers can meet the fundamental endpoints of precision medicine. This trend is creating profitable opportunities for information technology (IT) companies in the value chain, to efficiently manage large terabytes of data with advanced software systems.

EMR Systems and Policy-making Serve as Backbone of Biobanking Infrastructure

There is a growing need for advanced technology along with the need to streamline the process infrastructure of biobanks in developing economies. It is even more challenging for stakeholders in the biobanking market to support the infrastructure in developing countries due to the inadequacy of essential requirements such as basic Internet connectivity and stable electricity supply. As such, individuals and healthcare professionals in developing economies are making collective efforts to formulate policies that safeguard the infrastructure of biobanks, so that researchers can continue to deliver valuable contributions in the healthcare landscape.

Other challenges that are affecting the smooth flow of events in the biobanking market arise from the timely collection of samples and the question about ownership and consent to access specimens and data. To overcome these challenges, stakeholders are introducing electronic medical record (EMR) systems, where researchers across the globe can request and access samples & clinical data associated with biospecimens.

biobanking market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Biobanking Market

Analysts’ Viewpoint of Biobanking Market

The biobanking market is anticipated to grow at a CAGR of ~7%. This healthy growth rate has promising incremental opportunities for stakeholders in this market space. AI-driven process automation, data analytics, robotics, and the Internet are emerging as advanced technologies for developing virtual biobanks. However, the lack of privacy and security to safeguard patient data, samples, and specimens is an ongoing challenge for stakeholders. To overcome this challenge, they are collaborating with IT companies to avoid the risks of unethical utilization of data. Since therapeutics accounts for the highest revenue in the biobanking market, stakeholders should increase their focus on disease understanding, drug discovery, and development to support the healthcare infrastructure.

Biobanking Market: Overview and Insights

  • The global biobanking market was valued at ~US$ 2 Bn in the year 2018.
  • Growing at a CAGR of ~7%, the global biobanking market is projected to reach a value of ~US$ 3.6 Bn by the year 2027.
  • Biobanks are places that store human biological samples for future use. These are also known as bio-resources or bio-repositories.
  • A biobank is an essential tool that aids biomedical research in understanding the complex molecular and cellular mechanisms of various diseases. This, in turn, enables improving interventions for human health.
  • Increase in the demand for biobanks in genomics and biomedical research boosts the growth of the global biobanking market.
  • Different types of samples or biospecimen are stored in a biobank, such as blood products, human tissue, cell lines, and nucleic acid.
  • Different types of instruments, equipment, and software & services are utilized in a biobank.
  • Biobank samples are used in the production of pharmaceutical products, diagnosis of various diseases, drug development, and others.
  • In terms of equipment, temperature control systems are anticipated to be the leading segment, as major manufacturers are focusing on the launch of freezers & refrigerators, cryogenic storage systems, and other equipment for the storage of biobank samples. Increase in the number of biobanks in various countries and demand for advanced biobanking equipment in biobanks are the major drivers of the equipment segment.
  • Temperature control systems are anticipated to lead the biobanking market, as major manufacturers are focusing on the launch of freezers & refrigerators, cryogenic storage systems, and other equipment for the storage of biobank samples. 

Biobanking Market: Drivers

  • A biobank is an essential tool in biomedical research, which helps understand the complex molecular and cellular mechanisms in the development of various diseases. This also enables to improve interventions for human health.
  • Rise in genomic and proteomics research to study and identify genomic variations for rare diseases is projected to boost demand for biobanks in the next few years, as such, surging the biobanking market over the forecast period.
  • Biobanks help identify new biomarkers and clarify the etiology of complex diseases.
  • Advancements in biobanking are likely to fuel the growth of the biobanking market during the forecast period. The adoption of laboratory information management systems (LIMS) by researchers for the storage and retrieval of samples has increased in the past few years, which also acts as a driver for the growth of the global biobanking market.
  • Rise in the prevalence of life-threatening diseases such as cancer, heart diseases, neurological disorders, and several hematological disorders has increased the demand for blood-derived cell products. Furthermore, increasing number of biobanks in developed regions such as North America and Europe is likely to fuel the growth of the biobanking market.
  • New innovative product launches and advancements in biobanking are the major growth strategies adopted by market players in the biobanking market.
  • Rise in the preference for automated equipment boosts the growth of the automated equipment segment in the global biobanking market.
  • Biobanks are facing increased cost pressure for the storage of samples. As the cost increases, biobanks are looking for flexibility in their automation solutions that could connect with numerous competing instrument platforms, offering more testing that biobanks require in the long term. Through automation, biobanks are likely to cut down on costs in the long term. 

Biobanking Market: Major Players

  • Leading players analyzed in the report on the biobanking market are
    • Thermo Fisher Scientific, Inc.
    • PHC Holdings Corporation (Panasonic Healthcare)
    • Hamilton Company
    • Chart Industries, Inc.
    • VWR International
    • LLC (Avantor, Inc.)
    • QIAGEN N.V.
    • Greiner AG
    • Brooks Automation, Inc.
    • Merck KGaA
    • Tecan Trading AG.
  • Each of these players in the biobanking market have been profiled based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
  • Major biobank equipment manufacturers are focusing on the launch of automated equipment for biobanking, so as to provide more accuracy and help maintain the quality of biobank samples.
  • Increasing number of biobanks, launch of new advanced automated equipment in developing countries, and mergers & acquisitions are the key strategies adopted by leading players in the biobanking market. Several companies are focusing on new product launches with the help of local players on a global level.

Biobanking Market - Scope of the Report

TMR’s report on the global biobanking market studies the past as well as current growth trends and opportunities, to gain valuable insights of the indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global biobanking market for the period of 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biobanking market from 2019 to 2027.

The report is prepared after extensive research. Primary research involved bulk of the research efforts, wherein, analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players’ product literature, annual reports, press releases, and relevant documents to understand the biobanking market.

 

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of the top-down and bottom-up approach to study various attributes of the biobanking market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global biobanking market. These serve as valuable tools for existing market players as well as for entities interested in entering the global biobanking market.

The report delves into the competitive landscape of the global biobanking market. Key players operating in the global biobanking market are identified, and each one of them is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global biobanking market that are profiled in this report.

Key Questions Answered in the Biobanking Market Report

  • What is the sales/revenue expected to be generated by biobanks across all regions during the forecast period?
  • What are the opportunities in the biobanking market?
  • What are the major drivers, restraints, and threats in the biobanking market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What is the market position of different companies operating in the global biobanking market?

Biobanking Market - Research Objectives and Research Approach

The comprehensive report on the global biobanking market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study, key vendors and distributors operating in the market, and the regulatory scenario for the approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Global Biobanking Market - Segmentation

TMR’s study on the global biobanking market includes information divided into five segments: product, biospecimen, application, storage, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global biobanking market are discussed in detail.

Product

Equipment

Consumables

Software & Services

Biospecimen

Blood Products

Human Tissues

Cell Lines

Nucleic Acids

Others

Application

Therapeutics

Clinical Diagnostics

Drug Discovery & Development

Others

Storage

Manual

Automated

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

1. Preface

    1.1. Report Scope and Market Segmentation 

    1.2. Research Highlights

2. Assumptions and Research Methodology 

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Biobanking Market: Market Snapshot

4. Market Overview

    4.1. Global Biobanking Market: Product Overview

    4.2. Global Biobanking Market: Key Industry Developments

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Biobanking Market Revenue Projections, 2017–2027

    4.5. Global Biobanking Market Outlook

5. Market Outlook

    5.1. Key Mergers & Acquisitions

    5.2. Technological Advancements

    5.3. Healthcare Industry Overview

    5.4. Regulatory Scenario by Region/globally

    5.5. List of Major Biobanks, by Region

    5.6. List of Vendors Supporting Automated Biobanking

6. Global Biobanking Market Analysis, by Product

    6.1. Key Findings

    6.2. Introduction

    6.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Product

    6.4. Global Biobanking Market Forecast, by Product 

        6.4.1. Equipment

            6.4.1.1. Temperature Control Systems

                6.4.1.1.1. Freezers & Refrigerators

                6.4.1.1.2. Cryogenic Storage Systems

                6.4.1.1.3. Thawing Equipment

                6.4.1.1.4. Incubators & Centrifuges

            6.4.1.2. Alarms & Monitoring Systems

            6.4.1.3. Accessories & Other equipment

        6.4.2. Consumables

            6.4.2.1. Cryovials & Cryomolds

            6.4.2.2. Tubes

            6.4.2.3. Others

        6.4.3. Software & Services

    6.5. Global Biobanking Market Analysis, by Product, 2017–2027

7. Global Biobanking Market Analysis, by Biospecimen Type

    7.1. Key Findings

    7.2. Introduction

    7.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

    7.4. Global Biobanking Market Forecast, by Biospecimen Type

        7.4.1. Blood Products

        7.4.2. Human Tissues

        7.4.3. Cell Lines

        7.4.4. Nucleic Acids

        7.4.5. Others

    7.5. Global Biobanking Market Analysis, by Biospecimen Type, 2017–2027

8. Global Biobanking Market Analysis, by Application

    8.1. Key Findings

    8.2. Introduction

    8.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Application

    8.4. Global Biobanking Market Forecast, by Application

        8.4.1. Therapeutics

        8.4.2. Clinical Diagnostics

        8.4.3. Drug Discovery & Development

        8.4.4. Others

    8.5. Global Biobanking Market Analysis, by Application, 2017–2027

9. Global Biobanking Market Analysis, by Storage Type 

    9.1. Key Findings

    9.2. Introduction

    9.3. Global Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

    9.4. Global Biobanking Market Forecast, by Storage Type

        9.4.1. Manual

        9.4.2. Automated

    9.5. Global Biobanking Market Analysis, by Storage Type, 2017–2027

10. Global Biobanking Market Analysis, by Region

    10.1. Global Biobanking Market Scenario, by Country

    10.2. Global Biobanking Market Value Share and Attractiveness Analysis, by Region

    10.3. Global Biobanking Market Forecast, by Region

        10.3.1. North America

        10.3.2. Europe

        10.3.3. Asia Pacific

        10.3.4. Latin America

        10.3.5. Middle East & Africa

11. North America Biobanking Market Analysis

    11.1. Key Findings

    11.2. North America Biobanking Market Value Share and Attractiveness Analysis, by Country

    11.3. North America Biobanking Market Forecast, by Country

        11.3.1. U.S.

        11.3.2. Canada

    11.4. North America Biobanking Market Value Share and Attractiveness Analysis, by Product

    11.5. North America Biobanking Market Forecast, by Product

        11.5.1. Equipment

            11.5.1.1. Temperature Control Systems

                11.5.1.1.1. Freezers & Refrigerators

                11.5.1.1.2. Cryogenic Storage Systems

                11.5.1.1.3. Thawing Equipment

            11.5.1.2. Incubators & Centrifuges

            11.5.1.3. Alarms & Monitoring Systems

            11.5.1.4. Accessories & Other equipment

        11.5.2. Consumables

            11.5.2.1. Cryovials & Cryomolds

            11.5.2.2. Tubes

            11.5.2.3. Others

        11.5.3. Software & Services

    11.6. North America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

    11.7. North America Biobanking Market Forecast, by Biospecimen Type

        11.7.1. Blood Products

        11.7.2. Human Tissues

        11.7.3. Cell Lines

        11.7.4. Nucleic Acids

        11.7.5. Others

    11.8. North America Biobanking Market Value Share and Attractiveness Analysis, by Application

    11.9. North America Biobanking Market Forecast, by Application

        11.9.1. Therapeutics

        11.9.2. Clinical Diagnostics

        11.9.3. Drug Discovery & Development

        11.9.4. Others

    11.10. North America Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

    11.11. North America Biobanking Market Forecast, by Storage Type

        11.11.1. Manual

        11.11.2. Automated

12. Europe Biobanking Market Analysis

    12.1. Key Findings

    12.2. Europe Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Europe Biobanking Market Forecast, by Country/Sub-region

        12.3.1. Germany

        12.3.2. U.K.

        12.3.3. France

        12.3.4. Italy

        12.3.5. Spain

        12.3.6. Rest of Europe

    12.4. Europe Biobanking Market Value Share and Attractiveness Analysis, by Product

    12.5. Europe Biobanking Market Forecast, by Product

        12.5.1. Equipment

            12.5.1.1. Temperature Control Systems

                12.5.1.1.1. Freezers & Refrigerators

                12.5.1.1.2. Cryogenic Storage Systems

                12.5.1.1.3. Thawing Equipment

            12.5.1.2. Incubators & Centrifuges

            12.5.1.3. Alarms & Monitoring Systems

            12.5.1.4. Accessories & Other equipment

        12.5.2. Consumables

            12.5.2.1. Cryovials & Cryomolds

            12.5.2.2. Tubes

            12.5.2.3. Others

        12.5.3. Software & Services

    12.6. Europe Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

    12.7. Europe Biobanking Market Forecast, by Biospecimen Type

        12.7.1. Blood Products

        12.7.2. Human Tissues

        12.7.3. Cell Lines

        12.7.4. Nucleic Acids

        12.7.5. Others

    12.8. Europe Biobanking Market Value Share and Attractiveness Analysis, by Application

    12.9. Europe Biobanking Market Forecast, by Application

        12.9.1. Therapeutics

        12.9.2. Clinical Diagnostics

        12.9.3. Drug Discovery & Development

        12.9.4. Others

    12.10. Europe Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

    12.11. Europe Biobanking Market Forecast, by Storage Type

        12.11.1. Manual

        12.11.2. Automated

13. Asia Pacific Biobanking Market Analysis

    13.1. Key Findings

    13.2. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Asia Pacific Biobanking Market Forecast, by Country/Sub-region

        13.3.1. China

        13.3.2. Japan

        13.3.3. India

        13.3.4. Australia & New Zealand

        13.3.5. Rest of Asia Pacific

    13.4. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Product

    13.5. Asia Pacific Biobanking Market Forecast, by Product

        13.5.1. Equipment

            13.5.1.1. Temperature Control Systems

                13.5.1.1.1. Freezers & Refrigerators

                13.5.1.1.2. Cryogenic Storage Systems

                13.5.1.1.3. Thawing Equipment

            13.5.1.2. Incubators & Centrifuges

            13.5.1.3. Alarms & Monitoring Systems

            13.5.1.4. Accessories & Other equipment

        13.5.2. Consumables

            13.5.2.1. Cryovials & Cryomolds

            13.5.2.2. Tubes

            13.5.2.3. Others

        13.5.3. Software & Services

    13.6. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

    13.7. Asia Pacific Biobanking Market Forecast, by Biospecimen Type

        13.7.1. Blood Products

        13.7.2. Human Tissues

        13.7.3. Cell Lines

        13.7.4. Nucleic Acids

        13.7.5. Others

    13.8. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Application

    13.9. Asia Pacific Biobanking Market Forecast, by Application

        13.9.1. Therapeutics

        13.9.2. Clinical Diagnostics

        13.9.3. Drug Discovery & Development

        13.9.4. Others

    13.10. Asia Pacific Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

    13.11. Asia Pacific Biobanking Market Forecast, by Storage Type

        13.11.1. Manual

        13.11.2. Automated

14. Latin America Biobanking Market Analysis

    14.1. Key Findings

    14.2. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Latin America Biobanking Market Forecast, by Country/Sub-region

        14.3.1. Brazil

        14.3.2. Mexico

        14.3.3. Rest of Latin America

    14.4. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Product

    14.5. Latin America Biobanking Market Forecast, by Product

        14.5.1. Equipment

            14.5.1.1. Temperature Control Systems

                14.5.1.1.1. Freezers & Refrigerators

                14.5.1.1.2. Cryogenic Storage Systems

                14.5.1.1.3. Thawing Equipment

            14.5.1.2. Incubators & Centrifuges

            14.5.1.3. Alarms & Monitoring Systems

            14.5.1.4. Accessories & Other equipment

        14.5.2. Consumables

            14.5.2.1. Cryovials & Cryomolds

            14.5.2.2. Tubes

            14.5.2.3. Others

        14.5.3. Software & Services

    14.6. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

    14.7. Latin America Biobanking Market Forecast, by Biospecimen Type

        14.7.1. Blood Products

        14.7.2. Human Tissues

        14.7.3. Cell Lines

        14.7.4. Nucleic Acids

        14.7.5. Others

    14.8. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Application

    14.9. Latin America Biobanking Market Forecast, by Application

        14.9.1. Therapeutics

        14.9.2. Clinical Diagnostics

        14.9.3. Drug Discovery & Development

        14.9.4. Others

    14.10. Latin America Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

    14.11. Latin America Biobanking Market Forecast, by Storage Type

        14.11.1. Manual

        14.11.2. Automated

15. Middle East & Africa Biobanking Market Analysis

    15.1. Key Findings

    15.2. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Country/Sub-region

    15.3. Middle East & Africa Biobanking Market Forecast, by Country/Sub-region

        15.3.1. GCC Countries

        15.3.2. South Africa

        15.3.3. Rest of Middle East & Africa

    15.4. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Product

    15.5. Middle East & Africa Biobanking Market Forecast, by Product

        15.5.1. Equipment

            15.5.1.1. Temperature Control Systems

                15.5.1.1.1. Freezers & Refrigerators

                15.5.1.1.2. Cryogenic Storage Systems

                15.5.1.1.3. Thawing Equipment

            15.5.1.2. Incubators & Centrifuges

            15.5.1.3. Alarms & Monitoring Systems

            15.5.1.4. Accessories & Other equipment

        15.5.2. Consumables

            15.5.2.1. Cryovials & Cryomolds

            15.5.2.2. Tubes

            15.5.2.3. Others

        15.5.3. Software & Services

    15.6. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Biospecimen Type

    15.7. Middle East & Africa Biobanking Market Forecast, by Biospecimen Type

        15.7.1. Blood Products

        15.7.2. Human Tissues

        15.7.3. Cell Lines

        15.7.4. Nucleic Acids

        15.7.5. Others

    15.8. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Application

    15.9. Middle East & Africa Biobanking Market Forecast, by Application

        15.9.1. Therapeutics

        15.9.2. Clinical Diagnostics

        15.9.3. Drug Discovery & Development

        15.9.4. Others

    15.10. Middle East & Africa Biobanking Market Value Share and Attractiveness Analysis, by Storage Type

    15.11. Middle East & Africa Biobanking Market Forecast, by Storage Type

        15.11.1. Manual

        15.11.2. Automated

16. Competition Landscape

    16.1. Company Profiles

        16.1.1. Thermo Fisher Scientific, Inc. 

            16.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.1.2. Company Financials

            16.1.1.3. Growth Strategies

            16.1.1.4. SWOT Analysis

        16.1.2. PHC Holdings Corporation (Panasonic Healthcare) 

            16.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.2.2. Growth Strategies

            16.1.2.3. SWOT Analysis

        16.1.3. Hamilton Company 

            16.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.3.2. Company Financials

            16.1.3.3. Growth Strategies

            16.1.3.4. SWOT Analysis

        16.1.4. Chart Industries, Inc. 

            16.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.4.2. Company Financials

            16.1.4.3. Growth Strategies

            16.1.4.4. SWOT Analysis

        16.1.5. VWR International, LLC. (Avantor, Inc.) 

            16.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.5.2. Growth Strategies

            16.1.5.3. SWOT Analysis

        16.1.6. QIAGEN N.V. 

            16.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.6.2. Company Financials

            16.1.6.3. Growth Strategies

            16.1.6.4. SWOT Analysis

        16.1.7. Greiner AG 

            16.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.7.2. Company Financials

            16.1.7.3. Growth Strategies

            16.1.7.4. SWOT Analysis

        16.1.8. Brooks Automation, Inc.

            16.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.8.2. Company Financials

            16.1.8.3. Growth Strategies

            16.1.8.4. SWOT Analysis

        16.1.9. Merck KGaA 

            16.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.9.2. Company Financials

            16.1.9.3. Growth Strategies

            16.1.9.4. SWOT Analysis

        16.1.10. Tecan Trading AG

            16.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.1.10.2. Company Financials

            16.1.10.3. Growth Strategies

            16.1.10.4. SWOT Analysis

List of Tables

Table 01: Biobanking Market Merger and Acquisition Deals 

Table 02: Biobanking Market Merger and Acquisition Deals 

Table 03: Health Care Expenditure, by Major Countries, 2017

Table 04: List of Major Biobanks, by Country

Table 05: Global Biobanking Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 06: Global Biobanking Market Value (US$ Mn) Forecast, by Equipment, 2017–2027

Table 07: Global Biobanking Market Value (US$ Mn) Forecast, by Temperature Control Systems, 2017–2027

Table 08: Global Biobanking Market Value (US$ Mn) Forecast, by Consumables, 2017–2027

Table 09: Global Biobanking Market Value (US$ Mn) Forecast, by Biospecimen Type, 2017–2027

Table 10: Global Biobanking Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 11: Global Biobanking Market Value (US$ Mn) Forecast, by Storage Type, 2017–2027

Table 12: Global Biobanking Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 13: North America Biobanking Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 14: North America Biobanking Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 15: North America Biobanking Market Value (US$ Mn) Forecast, by Equipment, 2017–2027

Table 16: North America Biobanking Market Value (US$ Mn) Forecast, by Temperature Control Systems, 2017–2027

Table 17: North America Biobanking Market Value (US$ Mn) Forecast, by Consumables, 2017–2027

Table 18: North America Biobanking Market Value (US$ Mn) Forecast, by Biospecimen Type, 2017–2027

Table 19: North America Biobanking Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 20: North America Biobanking Market Value (US$ Mn) Forecast, by Storage Type, 2017–2027

Table 21: Europe Biobanking Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Europe Biobanking Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 23: Europe Biobanking Market Value (US$ Mn) Forecast, by Equipment, 2017–2027

Table 24: Europe Biobanking Market Value (US$ Mn) Forecast, by Temperature Control Systems, 2017–2027

Table 25: Europe Biobanking Market Value (US$ Mn) Forecast, by Consumables, 2017–2027

Table 26: Europe Biobanking Market Value (US$ Mn) Forecast, by Biospecimen Type, 2017–2027

Table 27: Europe Biobanking Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 28: Europe Biobanking Market Value (US$ Mn) Forecast, by Storage Type, 2017–2027

Table 29: Asia Pacific Biobanking Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Asia Pacific Biobanking Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 31: Asia Pacific Biobanking Market Value (US$ Mn) Forecast, by Equipment, 2017–2027

Table 32: Asia Pacific Biobanking Market Value (US$ Mn) Forecast, by Temperature Control Systems, 2017–2027

Table 33: Asia Pacific Biobanking Market Value (US$ Mn) Forecast, by Consumables, 2017–2027

Table 34: Asia Pacific Biobanking Market Value (US$ Mn) Forecast, by Biospecimen Type, 2017–2027

Table 35: Asia Pacific Biobanking Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 36: Asia Pacific Biobanking Market Value (US$ Mn) Forecast, by Storage Type, 2017–2027

Table 37: Latin America Biobanking Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 38: Latin America Biobanking Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 39: Latin America Biobanking Market Value (US$ Mn) Forecast, by Equipment, 2017–2027

Table 40: Latin America Biobanking Market Value (US$ Mn) Forecast, by Temperature Control Systems, 2017–2027

Table 41: Latin America Biobanking Market Value (US$ Mn) Forecast, by Consumables, 2017–2027

Table 42: Latin America Biobanking Market Value (US$ Mn) Forecast, by Biospecimen Type, 2017–2027

Table 43: Latin America Biobanking Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 44: Latin America Biobanking Market Value (US$ Mn) Forecast, by Storage Type, 2017–2027

Table 45: Middle East & Africa Biobanking Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 46: Middle East & Africa Biobanking Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 47: Middle East & Africa Biobanking Market Value (US$ Mn) Forecast, by Equipment, 2017–2027

Table 48: Middle East & Africa Biobanking Market Value (US$ Mn) Forecast, by Temperature Control Systems, 2017–2027

Table 49: Middle East & Africa Biobanking Market Value (US$ Mn) Forecast, by Consumables, 2017–2027

Table 50: Middle East & Africa Biobanking Market Value (US$ Mn) Forecast, by Biospecimen Type, 2017–2027

Table 51: Middle East & Africa Biobanking Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 52: Middle East & Africa Biobanking Market Value (US$ Mn) Forecast, by Storage Type, 2017–2027

List of Figures

Figure 01: Global Biobanking Market Value (US$ Mn) and Forecast, 2019–2027

Figure 02: Global Biobanking Market Value Share (%), by Product, 2018

Figure 03: Global biobanking Market Value Share (%), by Biospecimen Type, 2018

Figure 04: Global Biobanking Market Value Share (%), by Application, 2018

Figure 05: Global Biobanking Market Value Share (%), by Storage Type, 2018

Figure 06: Global Biobanking Market Value Share (%), by Region, 2018

Figure 07: Global Biobanking Market Value Share Analysis, by Product, 2018 and 2027

Figure 08: Global Biobanking Market Attractiveness, by Product, 2019–2027

Figure 09: Global Biobanking Market Size Forecast (US$ Mn), by Equipment, 2017–2027

Figure 10: Global Biobanking Market Size Forecast (US$ Mn), by Consumables, 2017–2027

Figure 11: Global Biobanking Market Size Forecast (US$ Mn), by Software & Services, 2017–2027

Figure 12: Global Biobanking Market Value Share Analysis, by Biospecimen Type, 2018 and 2027

Figure 13: Global Biobanking Market Attractiveness, by Biospecimen Type, 2019–2027

Figure 14: Global Biobanking Market Value Forecast (US$ Mn), by Blood Products, 2017–2027

Figure 15: Global Biobanking Market Value Forecast (US$ Mn), by Human Tissues, 2017–2027

Figure 16: Global Biobanking Market Value Forecast (US$ Mn), by Cell Lines, 2017–2027

Figure 17: Global Biobanking Market Value Forecast (US$ Mn), by Nucleic Acids, 2017–2027

Figure 18: Global Biobanking Market Value Forecast (US$ Mn), by Others, 2017–2027

Figure 19: Global Biobanking Market Value Share, by Application, 2018 and 2027

Figure 20: Global Biobanking Market Attractiveness, by Application, 2019–2027

Figure 21: Global Biobanking Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027 

Figure 22: Global Biobanking Market Value (US$ Mn) Forecast, by Clinical Diagnostics, 2017–2027 

Figure 23: Global Biobanking Market Value (US$ Mn) Forecast, by Drug Discovery & Development, 2017–2027 

Figure 24: Global Biobanking Market Value (US$ Mn) Forecast, by Others, 2017–2027

Figure 25: Global Biobanking Market Value Share, by Storage Type, 2018 and 2027

Figure 26: Global Biobanking Market Attractiveness, by Storage Type, 2019–2027

Figure 27: Global Biobanking Market Value (US$ Mn) Forecast, by Manual, 2017–2027

Figure 28: Global Biobanking Market Value (US$ Mn) Forecast, by Automated, 2017–2027

Figure 29: Global Biobanking Market Value Share, by Region, 2018 and 2027 

Figure 30: Global Biobanking Market Attractiveness, by Region, 2019–2027

Figure 31: North America Biobanking Market Value Share Analysis, by Country, 2018 and 2027

Figure 32: North America Biobanking Market Attractiveness, by Country, 2019–2027

Figure 33: North America Biobanking Market Value Share Analysis, by Product, 2018 and 2027

Figure 34: North America Biobanking Market Attractiveness, by Product, 2019–2027

Figure 35: North America Biobanking Market Value Share Analysis, by Biospecimen Type, 2018 and 2027

Figure 36: North America Biobanking Market Attractiveness, by Biospecimen Type, 2019–2027

Figure 37: North America Biobanking Market Value Share, by Application, 2018 and 2027

Figure 38: North America Biobanking Market Attractiveness, by Application, 2019–2027

Figure 39: North America Biobanking Market Value Share, by Storage Type, 2018 and 2027

Figure 40: North America Biobanking Market Attractiveness, by Storage Type, 2019–2027

Figure 41: Europe Biobanking Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 42: Europe Biobanking Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 43: Europe Biobanking Market Value Share Analysis, by Product, 2018 and 2027

Figure 44: Europe Biobanking Market Attractiveness, by Product, 2019–2027

Figure 45: Europe Biobanking Market Value Share Analysis, by Biospecimen Type, 2018 and 2027

Figure 46: Europe Biobanking Market Attractiveness, by Biospecimen Type, 2019–2027

Figure 47: Europe Biobanking Market Value Share, by Application, 2018 and 2027

Figure 48: Europe Biobanking Market Attractiveness, by Application, 2019–2027

Figure 49: Europe Biobanking Market Value Share, by Storage Type, 2018 and 2027

Figure 50: Europe Biobanking Market Attractiveness, by Storage Type, 2019–2027

Figure 51: Asia Pacific Biobanking Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 52: Asia Pacific Biobanking Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 53: Asia Pacific Biobanking Market Value Share Analysis, by Product, 2018 and 2027

Figure 54: Asia Pacific Biobanking Market Attractiveness, by Product, 2019–2027

Figure 55: Asia Pacific Biobanking Market Value Share Analysis, by Biospecimen Type, 2018 and 2027

Figure 56: Asia Pacific Biobanking Market Attractiveness, by Biospecimen Type, 2019–2027

Figure 57: Asia Pacific Biobanking Market Value Share, by Application, 2018 and 2027

Figure 58: Asia Pacific Biobanking Market Attractiveness, by Application, 2019–2027

Figure 59: Asia Pacific Biobanking Market Value Share, by Storage Type, 2018 and 2027

Figure 60: Asia Pacific Biobanking Market Attractiveness, by Storage Type, 2019–2027

Figure 61: Latin America Biobanking Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 62: Latin America Biobanking Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 63: Latin America Biobanking Market Value Share Analysis, by Product, 2018 and 2027

Figure 64: Latin America Biobanking Market Attractiveness, by Product, 2019–2027

Figure 65: Latin America Biobanking Market Value Share Analysis, by Biospecimen Type, 2018 and 2027

Figure 66: Latin America Biobanking Market Attractiveness, by Biospecimen Type, 2019–2027

Figure 67: Latin America Biobanking Market Value Share, by Application, 2018 and 2027

Figure 68: Latin America Biobanking Market Attractiveness, by Application, 2019–2027

Figure 69: Latin America Biobanking Market Value Share, by Storage Type, 2018 and 2027

Figure 70: Latin America Biobanking Market Attractiveness, by Storage Type, 2019–2027

Figure 71: Middle East & Africa Biobanking Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 72: Middle East & Africa Biobanking Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 73: Middle East & Africa Biobanking Market Value Share Analysis, by Product, 2018 and 2027

Figure 74: Middle East & Africa Biobanking Market Attractiveness, by Product, 2019–2027

Figure 75: Middle East & Africa Biobanking Market Value Share Analysis, by Biospecimen Type, 2018 and 2027

Figure 76: Middle East & Africa Biobanking Market Attractiveness, by Biospecimen Type, 2019–2027

Figure 77: Middle East & Africa Biobanking Market Value Share, by Application, 2018 and 2027

Figure 78: Middle East & Africa Biobanking Market Attractiveness, by Application, 2019–2027

Figure 79: Middle East & Africa Biobanking Market Value Share, by Storage Type, 2018 and 2027

Figure 80: Middle East & Africa Biobanking Market Attractiveness, by Storage Type, 2019–2027

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Biobanking Market